Overview

The Safety and Efficacy of Roflumilast Foam in HS

Status:
NOT_YET_RECRUITING
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
This study investigates the efficacy of topical roflumilast foam in patients with HS.
Phase:
PHASE2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Roflumilast